CALUMET INC (CLMT)

US1314281049 - Common Stock

22  +0.25 (+1.15%)

After market: 22 0 (0%)

Fundamental Rating

1

CLMT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 209 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT has a bad profitability rating. Also its financial health evaluation is rather negative. CLMT is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

CLMT had negative earnings in the past year.
CLMT had a negative operating cash flow in the past year.
CLMT had negative earnings in 4 of the past 5 years.
In multiple years CLMT reported negative operating cash flow during the last 5 years.

1.2 Ratios

CLMT has a Return On Assets of -10.83%. This is amonst the worse of the industry: CLMT underperforms 88.24% of its industry peers.
The Return On Invested Capital of CLMT (0.72%) is worse than 80.88% of its industry peers.
Industry RankSector Rank
ROA -10.83%
ROE N/A
ROIC 0.72%
ROA(3y)-5.39%
ROA(5y)-5.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 0.24%, CLMT is doing worse than 82.84% of the companies in the same industry.
CLMT's Operating Margin has improved in the last couple of years.
The Gross Margin of CLMT (4.74%) is worse than 79.90% of its industry peers.
In the last couple of years the Gross Margin of CLMT has declined.
Industry RankSector Rank
OM 0.24%
PM (TTM) N/A
GM 4.74%
OM growth 3YN/A
OM growth 5Y13.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.26%
GM growth 5Y-2.85%

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLMT is destroying value.
There is no outstanding debt for CLMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
CLMT has a worse Altman-Z score (0.98) than 62.25% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACC0.07
WACC9.95%

2.3 Liquidity

CLMT has a Current Ratio of 0.63. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLMT has a Current ratio of 0.63. This is amonst the worse of the industry: CLMT underperforms 82.35% of its industry peers.
A Quick Ratio of 0.30 indicates that CLMT may have some problems paying its short term obligations.
CLMT has a worse Quick ratio (0.30) than 93.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.3

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CLMT have decreased strongly by -630.77% in the last year.
CLMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 67.45% yearly.
CLMT shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.23%.
CLMT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.63% yearly.
EPS 1Y (TTM)-630.77%
EPS 3YN/A
EPS 5Y67.45%
EPS Q2Q%-193.65%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y22.61%
Revenue growth 5Y3.63%
Sales Q2Q%-4.26%

3.2 Future

The Earnings Per Share is expected to grow by 39.49% on average over the next years. This is a very strong growth
CLMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.34% yearly.
EPS Next Y-459.45%
EPS Next 2Y-41.5%
EPS Next 3Y8.67%
EPS Next 5Y39.49%
Revenue Next Year-1.07%
Revenue Next 2Y-0.98%
Revenue Next 3Y-4.05%
Revenue Next 5Y6.34%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 77.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.27

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.5%
EPS Next 3Y8.67%

More info and screens

0

5. Dividend

5.1 Amount

CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (1/13/2025, 8:11:12 PM)

After market: 22 0 (0%)

22

+0.25 (+1.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners27.34%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change-1.45%
Market Cap1.89B
Analysts78.33
Price Target25.76 (17.09%)
Short Float %8.47%
Short Ratio7.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.46%
Min EPS beat(2)-55.7%
Max EPS beat(2)14.77%
EPS beat(4)2
Avg EPS beat(4)-16.15%
Min EPS beat(4)-55.7%
Max EPS beat(4)25.47%
EPS beat(8)4
Avg EPS beat(8)-659.22%
EPS beat(12)4
Avg EPS beat(12)-483.07%
EPS beat(16)6
Avg EPS beat(16)-330.41%
Revenue beat(2)2
Avg Revenue beat(2)12.12%
Min Revenue beat(2)10.98%
Max Revenue beat(2)13.26%
Revenue beat(4)4
Avg Revenue beat(4)9.27%
Min Revenue beat(4)3.37%
Max Revenue beat(4)13.26%
Revenue beat(8)7
Avg Revenue beat(8)8.38%
Revenue beat(12)11
Avg Revenue beat(12)11.76%
Revenue beat(16)15
Avg Revenue beat(16)12.2%
PT rev (1m)0%
PT rev (3m)15.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2790%
EPS NY rev (1m)-0.87%
EPS NY rev (3m)-71.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)-1.98%
Revenue NY rev (3m)3.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 26.27
EPS(TTM)-2.76
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS60.8
BVpS-7.83
TBVpS-7.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.83%
ROE N/A
ROCE 0.92%
ROIC 0.72%
ROICexc 0.74%
ROICexgc 0.74%
OM 0.24%
PM (TTM) N/A
GM 4.74%
FCFM N/A
ROA(3y)-5.39%
ROA(5y)-5.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.06%
ROICexc growth 3YN/A
ROICexc growth 5Y16.35%
OM growth 3YN/A
OM growth 5Y13.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.26%
GM growth 5Y-2.85%
F-Score2
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.4
Cap/Depr 56.68%
Cap/Sales 1.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.3
Altman-Z 0.98
F-Score2
WACC9.95%
ROIC/WACC0.07
Cap/Depr(3y)269.2%
Cap/Depr(5y)179.87%
Cap/Sales(3y)6.86%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-630.77%
EPS 3YN/A
EPS 5Y67.45%
EPS Q2Q%-193.65%
EPS Next Y-459.45%
EPS Next 2Y-41.5%
EPS Next 3Y8.67%
EPS Next 5Y39.49%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y22.61%
Revenue growth 5Y3.63%
Sales Q2Q%-4.26%
Revenue Next Year-1.07%
Revenue Next 2Y-0.98%
Revenue Next 3Y-4.05%
Revenue Next 5Y6.34%
EBIT growth 1Y-94.99%
EBIT growth 3YN/A
EBIT growth 5Y18.05%
EBIT Next Year-41.4%
EBIT Next 3Y20.52%
EBIT Next 5Y20.12%
FCF growth 1Y53.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.97%
OCF growth 3YN/A
OCF growth 5YN/A